Healthcare Management News - UPDATE 1-U.S. FTC eyes licensing plan for J&J-Guidant deal

WASHINGTON, Sept 26 (Reuters) - U.S. authorities are considering requiring Johnson & Johnson (JNJ.N: Quote, Profile, Research) to license a key cardiac stent technology to Abbott Laboratories Inc. (

http://c.moreover.com/click/here.pl?r397139344